Suchergebnisse - "Capdevila, Jaume"

PubPharm (283)

101

Clinical and Translational Challenges in Thyroid Cancer

enthalten in: Current medicinal chemistry | 2020

von Hernando, J. | Ros, J. | Arroyo, A. | +1

102

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

enthalten in: International journal of cancer | 2020

von Sclafani, F. | Wilson, S. | Cunningham, D. | +12

103

VITAL phase 2 study : Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02)

enthalten in: Cancer Medicine | 2020

von Feliu, J. | Garcia‐Carbonero, R. | Capdevila, J. | +17

104

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

enthalten in: International Journal of Cancer | 2020

von Sclafani, F. | Wilson, S. | Cunningham, D. | +12

105

The PALBONET Trial : A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE‐1407)

enthalten in: The oncologist | 2020

von Grande, E. | Teulé, A. | Alonso‐Gordoa, T. | +15

106

Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors

enthalten in: The oncologist | 2019

von Capdevila, J. | Hernando, J. | Perez-Hoyos, S. | +2

107

Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma : The GEMCAD 1402 Randomized Clinical Trial

enthalten in: JAMA oncology | 2019

von Fernández-Martos, C. | Pericay, C. | Losa, F. | +17

108

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

enthalten in: The oncologist | 2019

von Garcia-Carbonero, R. | Marquez-Rodas, I. | de la Cruz-Merino, L. | +7

109

Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib : comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)

enthalten in: British journal of cancer | 2019

von Solis-Hernandez, M. | Fernandez Del Valle, A. | Carmona-Bayonas, A. | +15

110

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog : The GETNE-TRASGU Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Carmona-Bayonas, A. | Jiménez-Fonseca, P. | Lamarca, �. | +26